- Aytu BioPharma ( NASDAQ: AYTU ) announced a 1-for-20 reverse stock split of its outstanding common stock, effective on January 6, 2023.
- Beginning tomorrow, January 6, 2023, the Company's common stock will trade on a split-adjusted basis.
- The company's Board of Directors implemented the reverse stock split with the objective of regaining compliance with the $1.00 minimum bid price requirement of Nasdaq.
- To comply with this requirement, the closing bid price of the Company's common stock must be at least $1.00 per share for a minimum of 10 consecutive business days prior to May 22, 2023.
- Stock dumps 95% .
For further details see:
Aytu BioPharma down 95% on 1-for-10 reverse stock split to regain Nasdaq compliance